Insider · CIK 0001296549

Belldegrun Arie

CIK 0001296549 Name as filed on the most recent filing

Filed as Belldegrun Arie (20)

31 transaction lines · from 20 filings · filed 2007-03-09 to 2025-09-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

29 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-09-12 P, Open-market purchase LB Pharmaceuticals IncLBRX 2 lines 4,999,995, acquired Open Form 4 filing 0001193125-25-204935
2024-05-16 P, Open-market purchase Allogene Therapeutics, Inc.ALLO 4,999,997, acquired Open Form 4 filing 0001737287-24-000042
2022-01-12 P, Open-market purchase Allogene Therapeutics, Inc.ALLO 1,953,491, acquired Open Form 4 filing 0001214659-22-000701
2020-06-04 P, Open-market purchase Allogene Therapeutics, Inc.ALLO 2 lines 6,879,954, acquired Open Form 4 filing 0001214659-20-005383
2018-10-15 P, Open-market purchase Allogene Therapeutics, Inc.ALLO 3,500,010, acquired Open Form 4 filing 0001209191-19-009724
2018-10-15 P, Open-market purchase Allogene Therapeutics, Inc.ALLO 630,000, acquired Open Form 4 filing 0001209191-18-055372
2017-09-25 S, Open-market sale Kite Pharma, Inc.KITE 4,733,605, disposed Open Form 4 filing 0001209191-17-054193
2017-05-09 P, Open-market purchase Kite Pharma, Inc.KITE 1,165,690, acquired Open Form 4 filing 0001209191-17-030899
2016-12-20 S, Open-market sale Kite Pharma, Inc.KITE 177,654, disposed Open Form 4 filing 0001209191-16-156541
2016-08-15 P, Open-market purchase Arno Therapeutics, IncARNI Not reported Open Form 4 filing 0000914190-16-000741
2016-01-12 P, Open-market purchase Arno Therapeutics, IncARNI 2 lines 756,821, acquired Open Form 4 filing 0000914190-16-000517
2013-10-29 P, Open-market purchase Arno Therapeutics, IncARNI Not reported Open Form 4 filing 0000914190-13-000786
2013-10-29 P, Open-market purchase Arno Therapeutics, IncARNI Not reported Open Form 4 filing 0000914190-13-000786
2013-10-29 P, Open-market purchase Arno Therapeutics, IncARNI Not reported Open Form 4 filing 0000914190-13-000786
2013-10-29 P, Open-market purchase Arno Therapeutics, IncARNI Not reported Open Form 4 filing 0000914190-13-000787
2008-02-21 P, Open-market purchase Cougar Biotechnology, Inc.CGRB 2 lines 134,997, acquired Open Form 4 filing 0001179110-08-005965
2008-02-21 P, Open-market purchase Cougar Biotechnology, Inc.CGRB 2 lines 134,997, acquired Open Form 4 filing 0001179110-08-004871
2007-12-18 P, Open-market purchase Cougar Biotechnology, Inc.CGRB 457,500, acquired Open Form 4 filing 0001179110-07-023819
2007-06-18 P, Open-market purchase Cougar Biotechnology, Inc.CGRB 88,430, acquired Open Form 4 filing 0001179110-07-019310
2007-06-18 P, Open-market purchase Cougar Biotechnology, Inc.CGRB 88,430, acquired Open Form 4 filing 0001179110-07-013411
2007-05-08 P, Open-market purchase Cougar Biotechnology, Inc.CGRB 149,810, acquired Open Form 4 filing 0001179110-07-009702
2007-02-27 P, Open-market purchase Cougar Biotechnology, Inc.CGRB 18,550, acquired Open Form 4 filing 0001179110-07-005738
2007-02-26 P, Open-market purchase Cougar Biotechnology, Inc.CGRB 4 lines 256,425, acquired Open Form 4 filing 0001179110-07-005738

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 27
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Belldegrun Arie, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001296549

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.